Ironwood Investment Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-2,842
| Closed | -$22K | – | 173 |
|
2024
Q3 | $22K | Buy |
2,842
+141
| +5% | +$1.09K | 0.01% | 172 |
|
2024
Q2 | $16.2K | Sell |
2,701
-100
| -4% | -$600 | 0.01% | 168 |
|
2024
Q1 | $25.3K | Buy |
2,801
+286
| +11% | +$2.58K | 0.01% | 173 |
|
2023
Q4 | $23.8K | Sell |
2,515
-346
| -12% | -$3.28K | 0.01% | 166 |
|
2023
Q3 | $34K | Sell |
2,861
-1
| -0% | -$12 | 0.02% | 161 |
|
2023
Q2 | $70.1K | Sell |
2,862
-139
| -5% | -$3.41K | 0.04% | 162 |
|
2023
Q1 | $93.9K | Buy |
3,001
+93
| +3% | +$2.91K | 0.06% | 157 |
|
2022
Q4 | $205K | Sell |
2,908
-200
| -6% | -$14.1K | 0.14% | 142 |
|
2022
Q3 | $268K | Buy |
3,108
+7
| +0.2% | +$604 | 0.19% | 128 |
|
2022
Q2 | $256K | Buy |
3,101
+4
| +0.1% | +$330 | 0.17% | 133 |
|
2022
Q1 | $515K | Buy |
3,097
+31
| +1% | +$5.16K | 0.28% | 114 |
|
2021
Q4 | $513K | Buy |
+3,066
| New | +$513K | 0.25% | 119 |
|